Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: dyspnea major surgical or invasive procedure: none history of present illness: mr. is a 69 year old man with severe chf (ef <20%), htn, dm 2 presenting with increasing shortness of breath and pedal edema for the past 7 days. family reports that he stopped taking all of his medications approximately 5 days pta because he could no longer taste anything and was concerned that one of his meds was causing this. he came to the ed because he could no longer walk around the house without becoming short of breath and he had to sleep sitting straight up. in addition he reported a dry cough productive of grey sputum, lightheadedness/dizziness. he denied fever and chest pain. past medical history: chf, ef 20% in chronic renal insufficiency dm2 htn hypercholesterolemia obesity benign prostatic hypertrophy. bronchitis. possible obstructive sleep apnea multifocal atrial tachycardia social history: rare etoh. quit tobacco 12 years ago. the patient lives with girlfriend, and cats. was working in a steel mill in from to . close to son. family history: family history: noncontributory physical exam: initial ccu exam vs: bp's 102-128/80-90, hr 70-80's t95.6 o2 92%on 6l vm gen: respirations, somnolent, apparent respiratory distress heent: jvp elevated cv: distant heart sounds, rrr no murmur audible abd: obese, soft, nontender, nondistended bs + lungs: anterior lung fields with crackles bilaterally extremities: cool with 2+pitting edema bilaterally pertinent results: 11:30am wbc-10.5 rbc-5.95 hgb-16.7 hct-49.2 mcv-83 mch-28.0 mchc-33.9 rdw-16.0* 11:30am neuts-74.2* lymphs-16.2* monos-8.0 eos-1.4 basos-0.2 11:30am glucose-206* urea n-20 creat-1.3* sodium-143 potassium-5.2* chloride-108 total co2-26 anion gap-14 11:30am plt count-371# 11:30am calcium-9.3 phosphate-4.3 magnesium-2.2 11:30am ck-mb-notdone probnp-7209* 11:30am ctropnt-0.05* 11:30am ck(cpk)-69 . ekg demonstrated atrial fibrillation,rate 90bpm, normal intervals, normal axis, pvc, <1mm st segment elevation in v1, v2. no significant change compared with prior. . hemodynamics on arrival to ccu cvp 12 pa 56/28 pcwp 27 co 5.8 ci 2.22 svr 690 . other testing: cxr - 1. slight perimediastinal vascular haze, increased interstitial markings, and bilateral lower lung field haze, all suggestive of mild fluid overload with probable layering posterior effusion. 2. left lower lobe/retrocardiac density is nonspecific and may represent underlying atelectasis or consolidation . tte the left atrium is elongated. left ventricular wall thicknesses are normal. the left ventricular cavity is mildly dilated. there is severe global left ventricular hypokinesis (lvef <20 %). no masses or thrombi are seen in the left ventricle. the right ventricular cavity is mildly dilated with severe global free wall hypokinesis. the aortic valve leaflets appear structurally normal with good leaflet excursion. there is no aortic valve stenosis. no aortic regurgitation is seen. the mitral valve appears structurally normal with trivial mitral regurgitation. there is borderline pulmonary artery systolic hypertension. there is no pericardial effusion. compared with the prior study (images reviewed) of , the findings are similar (left ventricular dysfunction was also global on review of the prior study and right ventricular free wall hypokinesis was also present. borderline pulmonary artery systolic hypertension is now suggested. brief hospital course: 1. dyspnea/chf: the patient's worsened dyspnea was thought to be due to a chf exacerbation in the setting of medication non-compliance and pneumonia. upon arrival to the ccu, the patient was exhibiting respirations, and due to somnolence and increasing hypercapnia required intubation. a pa catheter was placed, and he was started on dobutamine, and responded well to diuresis with lasix and diuril. he was extubated on , and his respiratory status improved with continued diuresis. he will be discharged on lasix 80 as he remains volume overloaded; diuretics will be titrated at his followup heart failure clinic visit in the next week. he continued his home beta blocker and acei. spironolactone was started, and he will continue this as an outpatient. his electrolytes and renal function should be reassessed at his next clinic visit on . . 2. mat/tachycardia: mr. had a run of tachycardia to the 150's in the ed that responded well to lopressor by report. on the floor, he continued to have brief episodes of nsvt and pvcs on telemetry. . 3. cad: patient continued on aspirin, betablocker, statin, and acei. . 4. pneumonia: the patient was initially treated with azithromycin and ceftriaxone and in the ed, subsequently on levofloxacin and flagyl. he will complete a 7d course of levofloxacin to end on . . 5. diabetes: the patient was treated with insulin while in the ccu, with resumption of his metformin subsequently. given his baseline elevated creatinine, an alternative oral than metformin may be preferable. this can be readdressed at his next outpatient followup appointment. . 5. sleep apnea: cpap continued . 6. traumatic foley insertion: urology was consulted for hematuria, per urology balloon inflated in the prostatic fossa, foley repositioned and irrigated with good urine output and resolution of hematuria. . #code status - full . #contact - long time girlfriend medications on admission: lipitor 80mg po daily asa 325mg po daily toprol xl 200mg po daily lisinopril 40mg po daily metformin 850mg po bid lasix 40mg po bid discharge medications: 1. metformin 850 mg tablet sig: one (1) tablet po bid (2 times a day). 2. lisinopril 20 mg tablet sig: two (2) tablet po daily (daily). 3. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). 4. lasix 80 mg tablet sig: one (1) tablet po twice a day. disp:*60 tablet(s)* refills:*2* 5. toprol xl 200 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po once a day. 6. spironolactone 25 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 7. 180 mg tablet sig: one (1) tablet po once a day as needed for allergy symptoms. 8. advair diskus 250-50 mcg/dose disk with device sig: one (1) inhalation twice a day. 9. albuterol sulfate 90 mcg/actuation hfa aerosol inhaler sig: two (2) puffs inhalation every 4-6 hours as needed for shortness of breath or wheezing. 10. aspirin 81 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 11. ambien 5 mg tablet sig: one (1) tablet po at bedtime as needed for insomnia. 12. levofloxacin 750 mg tablet sig: one (1) tablet po once a day for 1 doses: take sunday . disp:*1 tablet(s)* refills:*0* discharge disposition: home with service facility: homecare discharge diagnosis: 1. chf exacerbation 2. pneumonia discharge condition: fair discharge instructions: you came into the hospital due to shortness of breath. your symptoms were due to worsening of your congestive heart failure in the setting of stopping your heart failure medications. please take your medications every day as directed. if you believe you are having side effects from the medications or other problems taking them please call your doctor before stopping the medications. you have one more dose of antibiotics (levofloxacin) to take to complete the course of treatment for your pneumonia. please take the levofloxacin on sunday , even if you are feeling well before then. weigh yourself every morning, md if weight > 3 lbs. adhere to 2 gm sodium diet call your doctor and seek medical attention at once if you develop: ** worsening shortness of breath, chest discomfort, fevers, chills, or sweats, worsening cough, or other symptoms that worry you followup instructions: please follow up with on tuesday at 1pm procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube systemic arterial pressure monitoring diagnoses: pneumonia, organism unspecified obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic kidney disease, unspecified paroxysmal ventricular tachycardia acute respiratory failure other specified cardiac dysrhythmias other and unspecified angina pectoris automatic implantable cardiac defibrillator in situ personal history of noncompliance with medical treatment, presenting hazards to health combined systolic and diastolic heart failure, unspecified other complications due to genitourinary device, implant, and graft 

Answer: The patient is high likely exposed to